The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.

Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's ...

Lyumjev (insulin lispro-aabc) is prescribed to manage blood sugar levels in certain people with type 1 or 2 diabetes. The drug comes as a liquid solution for injection as directed by your doctor. The ...

Real-world data demonstrate that the MiniMed 780G system effectively controls glucose levels in users who do not administer bolus insulin.

Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...

Afrezza (insulin human) is prescribed to help manage blood sugar in adults with diabetes. The drug comes as powder with a cartridge and device for inhaling. You take it at the beginning of each meal.

Afrezza (insulin human) is a brand-name inhaled insulin prescribed to manage blood sugar in adults with diabetes. It comes as a powder that you typically take at mealtimes. The dosage can vary based ...